You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Ketamine administration in depressive disorders: a systematic review and meta-analysis
|
|---|---|
| Published in |
Psychopharmacology, July 2014
|
| DOI | 10.1007/s00213-014-3664-5 |
| Pubmed ID | |
| Authors |
Guillaume Fond, Anderson Loundou, Corentin Rabu, Alexandra Macgregor, Christophe Lançon, Marie Brittner, Jean-Arthur Micoulaud-Franchi, Raphaelle Richieri, Philippe Courtet, Mocrane Abbar, Matthieu Roger, Marion Leboyer, Laurent Boyer |
| Abstract |
Ketamine's efficacy in depressive disorders has been established in several controlled trials. The aim of the present study was to determine whether or not ketamine administration significantly improves depressive symptomatology in depression and more specifically in major depressive disorder (MDD), bipolar depression, resistant depression (non-ECT studies), and as an anesthetic agent in electroconvulsive therapy (ECT) for resistant depression (ECT studies). Secondary outcomes were the duration of ketamine's effect, the efficacy on suicidal ideations, the existence of a dose effect, and the safety/tolerance of the treatment. |
X Demographics
The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 21% |
| United Kingdom | 2 | 11% |
| United States | 2 | 11% |
| Denmark | 1 | 5% |
| Unknown | 10 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 74% |
| Scientists | 4 | 21% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 481 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Ireland | 1 | <1% |
| Canada | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 477 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 75 | 16% |
| Researcher | 58 | 12% |
| Student > Master | 57 | 12% |
| Other | 40 | 8% |
| Student > Ph. D. Student | 37 | 8% |
| Other | 103 | 21% |
| Unknown | 111 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 147 | 31% |
| Psychology | 51 | 11% |
| Neuroscience | 46 | 10% |
| Agricultural and Biological Sciences | 24 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 22 | 5% |
| Other | 51 | 11% |
| Unknown | 140 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 81. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2022.
All research outputs
#503,852
of 24,770,025 outputs
Outputs from Psychopharmacology
#140
of 5,573 outputs
Outputs of similar age
#4,610
of 234,288 outputs
Outputs of similar age from Psychopharmacology
#2
of 48 outputs
Altmetric has tracked 24,770,025 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,573 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 234,288 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.